1. Sabatine MS, et al. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015 Apr 16;372(16):1500-9.
  2. Koren MJ, et al. Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial. Circulation. 2014 Jan 14;129(2):234-43.
  3. Keveyis (dichlorphenamide) prescribing information. Taro Pharmaceuticals; Hathorne, NY. August 2015.
  4. BEGONIA trial investigators. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial. J Sex Med. 2013;10:1807-15.
  5. Synjardy (empagliflozin/metformin) prescribing information. Boehringer Ingelheim, Inc. Ridgefield, CT. August 2015.
  6. Moskowitz CH, et al. Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2015 May 9;385(9980):1853-62.
  7. OxyContin (oxycodone) prescribing information. Purdue Pharma L.P. Stamford, CT. August 2015.
  8. Zubsolv (buprenorphine/naloxone) prescribing information. Orexo Pharmaceuticals, Inc. Morristown, NJ. August 2015.
  9. Procysbi (cysteamine bitartrate) prescribing information. Raptor Pharmaceuticals, Inc. Novato, California. August 2015.
  10. Grainger JD, et al. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial. Lancet. 2015 Jul 28. pii: S0140-6736(15)61107-2.
  11. Behrens G, et al. Rilpivirine versus efavirenz with emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected patients with HIV-1 RNA ≤100,000 copies/mL: week 96 pooled ECHO/THRIVE subanalysis. AIDS Patient Care STDS. 2014 Apr;28(4):168-75.
  12. Aptiom (eslicarbazepine acetate) prescribing information. Sunovion Pharmaceuticals, Inc. Marlborough, MA. August 2015.

Contributor Information


Mary L Windle, PharmD
Editor-in-Chief, Medscape Drug Reference


  • Google+
  • LinkedIn